Cargando…
Cysteine is a limiting factor for glioma proliferation and survival
Nutritional intervention is becoming more prevalent as adjuvant therapy for many cancers in view of the tumor dependence on external sources for some nutrients. However, little is known about the mechanisms that make cancer cells require certain nutrients from the microenvironment. Herein, we report...
Autores principales: | Ruiz‐Rodado, Victor, Dowdy, Tyrone, Lita, Adrian, Kramp, Tamalee, Zhang, Meili, Jung, Jinkyu, Dios‐Esponera, Ana, Zhang, Lumin, Herold‐Mende, Christel C., Camphausen, Kevin, Gilbert, Mark R., Larion, Mioara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067152/ https://www.ncbi.nlm.nih.gov/pubmed/34856072 http://dx.doi.org/10.1002/1878-0261.13148 |
Ejemplares similares
-
DDRE-16. CYSTEINE IS AN ESSENTIAL AMINO ACID IN GLIOMAS
por: Ruiz-Rodado, Victor, et al.
Publicado: (2021) -
Metabolic biomarkers of radiotherapy response in plasma and tissue of an IDH1 mutant astrocytoma mouse model
por: Ruiz-Rodado, Victor, et al.
Publicado: (2022) -
DDRE-20. TARGETING SPHINGOLIPID PATHWAY REVEALS VULNERABILITY IN IDH1(MUT) GLIOMA
por: Dowdy, Tyrone, et al.
Publicado: (2021) -
Sphingolipid Pathway as a Source of Vulnerability in IDH1(mut) Glioma
por: Dowdy, Tyrone, et al.
Publicado: (2020) -
BIMG-10. IDH1 MUTATIONS INDUCE ORGANELLE DEFECTS VIA DYSREGULATED PHOSPHOLIPIDS
por: Yamasaki, Tomohiro, et al.
Publicado: (2021)